-
Biomerica expands contract manufacturing services amid rising demand
-
Biomerica partners with Henry Schein to market IBS test in US
-
Biomerica launches AI tool for IBS dietary management
-
UAE approves Biomerica home kidney test for diabetic patients
-
UAE approves Biomerica's home ulcer test for consumer use
-
Biomerica, Inc. (BMRA) Appoints Scott Madel as Chief Commercial Officer
-
Biomerica, Inc. (BMRA) Appoints Eric B. Chin to Board and Audit Committee Chair
-
Biomerica's (BMRA) inFoods IBS Clinical Study Results Published in June Issue of Gastroenterology
-
Biomerica, Inc. (BMRA): United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
-
Biomerica, Inc. (BMRA): United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
-
Biomerica, Inc. (BMRA) Announces 1-for-8 Reverse Stock Split
-
Biomerica (BMRA) Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
-
Biomerica's (BMRA) inFoods IBS Clinical Trial Results Published and Featured in Gastroenterology
-
Biomerica (BMRA) Announces UAE Ministry of Health and Prevention Approval of Fortel PSA
-
Biomerica, Inc. (BMRA) Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
-
Biomerica, Inc. (BMRA): Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
-
Biomerica (BMRA) Announces SFDA's Approval of At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

